Collectively, our comprehensive kinase activity analysis enables the identification of master kinases and the downstream outcomes of kinase activation in two HGG tumor models in which PI3K pathway activation is driven by different receptor tyrosine kinase mutations that are found in human HGG. This evidence concerns the gene NTRK1 and neoplasm.